Intuitive Surgical
ISRG
399.05
-8.19
-2.01%
Intuitive Surgical
US · ISRG
#157 by market cap
Listed 1970
399.05
-8.19
-2.01%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
A
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Improving
3 1
■ Upgrades■ Downgrades
- 3 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Oppenheimer moved from Hold to Buy on 2026-08-12.
Analyst consensus 18 analysts
Buy
Avg price target 510.35 +27.9%
Price target rangecurrent 399.05
Low454.00
Avg510.35
High685.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-21 | Wells Fargo | -- | Buy | 486.00 |
| 2026-10-21 | Bernstein | -- | Buy | 685.00 |
| 2026-10-21 | Piper Sandler | -- | Buy | 470.00 |
| 2026-10-21 | Raymond James | -- | Buy | 480.00 |
| 2026-10-21 | BofA Securities | -- | Buy | 470.00 |
| 2026-10-21 | Baird | -- | Buy | 550.00 |
| 2026-10-21 | Stifel | -- | Buy | 550.00 |
| 2026-10-21 | Erste Group | -- | Buy | -- |
| 2026-10-21 | Leerink Partners | -- | Buy | 503.00 |
| 2026-10-21 | Barclays | -- | Buy | 500.00 |
| 2026-10-21 | Oppenheimer | -- | Buy | 500.00 |
| 2026-10-21 | J.P. Morgan | -- | Buy | 475.00 |
| 2026-10-20 | BTIG | -- | Buy | 454.00 |
| 2026-10-20 | BMO Capital | -- | Buy | 518.00 |
| 2026-10-20 | Citi | -- | Buy | 500.00 |
| 2026-10-20 | RBC Capital | -- | Buy | 550.00 |
| 2026-10-19 | TD Cowen | -- | Buy | 485.00 |
| 2026-10-13 | UBS | -- | Buy | 500.00 |
| 2026-10-12 | BTIG | -- | Buy | 454.00 |
| 2026-10-12 | Leerink Partners | -- | Buy | 473.00 |
| 2026-10-07 | Piper Sandler | -- | Buy | 470.00 |
| 2026-10-07 | Barclays | -- | Buy | 485.00 |
| 2026-10-05 | Citi | -- | Buy | 500.00 |
| 2026-10-01 | RBC Capital | -- | Buy | 575.00 |
| 2026-09-21 | BofA Securities | -- | Buy | 470.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-12 | Oppenheimer | Hold → Buy | 500.00 |
| 2026-07-28 | UBS | Hold → Buy | 500.00 |
| 2026-03-11 | Citi | Hold → Buy | 590.00 |
| 2025-12-11 | Citi | Buy → Hold | 635.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-20 | After close | ±6.92% | -2.26% (in line) |
| 2026/Q2 | 2026-07-16 | After close | ±8.13% | -14.15% (beat) |
| 2026/Q1 | 2026-04-21 | After close | ±7.14% | +7.16% (beat) |
| 2025/Q4 | 2026-01-22 | After close | ±5.46% | -0.35% (in line) |
| 2025/Q3 | 2025-10-21 | After close | ±7.30% | +13.89% (beat) |
| 2025/Q2 | 2025-07-22 | After close | ±6.78% | -1.77% (in line) |
| 2025/Q1 | 2025-04-22 | After close | ±7.87% | +1.92% (in line) |
| 2024/Q4 | 2025-01-23 | After close | ±6.32% | -4.04% (in line) |
| 2024/Q3 | 2024-10-17 | After close | ±6.82% | +10.01% (beat) |
| 2024/Q2 | 2024-07-18 | After close | ±6.80% | +9.34% (beat) |
| 2023/Q4 | 2024-01-23 | After close | ±5.45% | -0.36% (in line) |
| 2023/Q3 | 2023-10-19 | After close | ±8.42% | -2.39% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.
Intuitive Surgical discussion 0 comments